Internal Medicine NewsPostmenopausal women with early breast cancer can go chemo-freeDecember 17, 2021Breast CancerOncologyWomen's Health
Internal Medicine NewsCardiovascular effects of breast cancer treatment vary based on weight, menopausal statusDecember 17, 2021Breast CancerOncologyObesity
Internal Medicine NewsCancer risk tied to some manufactured foodsDecember 16, 2021Breast CancerOncology
Internal Medicine NewsBreast cancer-related musculoskeletal pain alleviated with acupunctureDecember 16, 2021Breast CancerOncology
Internal Medicine NewsMore evidence ties some antipsychotics to increased breast cancer riskDecember 15, 2021Breast CancerOncologyMental Health
Internal Medicine NewsSacituzumab govitecan effective in Black mTNBC patientsDecember 15, 2021OncologyBreast Cancer
Internal Medicine NewsPD-L1 cutoff for pembrolizumab in mTNBC confirmedDecember 15, 2021OncologyBreast Cancer
Internal Medicine NewsPembrolizumab improves event-free survival in early TNBCDecember 15, 2021OncologyBreast Cancer
Internal Medicine NewsAntibiotic use associated with triple-negative breast cancer mortalityDecember 13, 2021OncologyBreast Cancer
Internal Medicine NewsOmega-3 supplements may impact breast cancer riskDecember 13, 2021OncologyBreast Cancer
Internal Medicine NewsWomen struggle with benzodiazepine addiction post chemotherapy treatmentDecember 13, 2021OncologyBreast CancerAddiction Medicine
Internal Medicine News‘Surprising’ lack of benefit to adding palbociclib to endocrine therapy in early HR+/HER2– breast cancerDecember 13, 2021Breast Cancer
Internal Medicine NewsThe evolving HER2+ metastatic breast cancer landscape: Novel agents and promising combination therapiesDecember 11, 2021Breast Cancer
Internal Medicine NewsOngoing HER2 breast cancer therapy may cost an additional $68,000 per patientDecember 10, 2021OncologyBreast Cancer
Internal Medicine NewsVitamin D counters bone density loss with aromatase inhibitorsDecember 10, 2021OncologyBreast Cancer
